Brook Kilian
Family · Englewood, CONPI 1215518709
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,674 of the $8,344 with a category attached, or 68.0%. It is spread thinly across 26 manufacturers, the largest accounting for just 19.8%. Among family clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 191 payments — averaging $43.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Painteq LLC$2K
- AbbVie$1K
- Abbott$1K
- Boston Scientific$1K
- Relievant Medsystems, Inc.$870
- Saluda Medical Americas, Inc.$344
- plus $2K from 20 others
What the payments were for
- Travel & lodging$1,52118%
- Food & beverage$5,67468%
- Education$1,14914%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Painteq LLC | 7 | $1,656 |
| AbbVie(2 entities) | 70 | $1,383 |
| Abbott | 14 | $1,340 |
| Boston Scientific | 17 | $1,042 |
| Relievant Medsystems, Inc. | 8 | $870 |
| Saluda Medical Americas, Inc. | 4 | $344 |
| Pfizer | 14 | $289 |
| Scilex Pharmaceuticals Inc. | 9 | $159 |
| Collegium Pharmaceutical, Inc. | 10 | $155 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $136 |
| Radius Health, Inc. | 2 | $125 |
| Si-bone, Inc. | 1 | $123 |
| Lundbeck LLC | 5 | $106 |
| Nevro Corp. | 1 | $91 |
| Medtronic | 1 | $75 |
| SPR Therapeutics, Inc | 2 | $72 |
| Lilly USA, LLC | 4 | $65 |
| Tonix Medicines, Inc. | 2 | $61 |
| Averitas Pharma Inc. | 3 | $58 |
| GRT US Holding, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| IBSA Pharma Inc. | 2 | $40 |
| Axonics, Inc. | 1 | $19 |
| Vertex | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Curonix LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$2,708
- PAINTEQ$1,522
- PROCLAIM$966
- QULIPTA$369
- Evoke$303
- UBRELVY$244
- GENERAL PAIN MANAGEMENT$143
- Tymlos$110
- WaveWriter Alpha Prime 16$104
How this compares
$8,344 in reported general payments places this provider in the 95th percentile of 2,182 family providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 46 | $62,022 |
| BelbucaBuprenorphine Hcl | 52 | $49,591 |
| Xtampza ErOxycodone Myristate | 68 | $43,119 |
| Levorphanol Tartrate | 12 | $41,086 |
| Nucynta ErTapentadol Hcl | 24 | $28,056 |
| OxycontinOxycodone Hcl | 39 | $25,482 |
| Aimovig AutoinjectorErenumab-Aooe | 27 | $21,068 |
| Nurtec OdtRimegepant Sulfate | 11 | $19,025 |
| Oxycodone Hcl | 669 | $14,113 |
| CambiaDiclofenac Potassium | 11 | $12,434 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 286 | $11,915 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 271 | $9,818 |
| Buprenorphine | 29 | $8,560 |
| Morphine Sulfate ErMorphine Sulfate | 195 | $6,444 |
| Fentanyl | 70 | $5,965 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Belbuca, Xtampza Er, Nucynta Er | $155 | $182,788190 claims |
| PfizerNurtec Odt | $289 | $19,02511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,182 family providers in Colorado.
Other family in Englewood
- Taylor CampbellEnglewood$16K
- Meagan MurgelEnglewood$11K
- Jennifer BurkeEnglewood$9K
- Annette WychgramEnglewood$8K
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
- Teal MeffordThornton$63K
- Jacquita JordanColorado Springs$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.